As a naturally inhibitor of mitochondrial complex I, intragastric administration of rotenone is believed to almost reproduce the typical pathological features of PD, that is, accumulated α-synuclein spreading from the enteric nervous system to the central nervous system and the loss of dopaminergic neurons. Here, SNCA is linked to Parkinson disease.